News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Reviews Blood Clot Risk with Bayer Corporation (BAY) Contraceptives


6/1/2011 8:39:36 AM

The U.S. Food and Drug Administration (FDA) said it is reviewing results from two studies that showed there is a higher risk of blood clots in women taking birth control pills containing the compound drospirenone.

The FDA said it is evaluating the conflicting results from these and earlier studies and reviewing the risks and benefits of drospirenone-containing birth control pills.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES